Your browser doesn't support javascript.
loading
Clinical and technical considerations for mediastinal Hodgkin lymphoma protontherapy based on a single-center early experience.
Loap, P; Goudjil, F; Dendale, R; Kirova, Y.
Affiliation
  • Loap P; Institut Curie, Department of Radiation Oncology, 75005 Paris, France.
  • Goudjil F; Institut Curie, Department of Radiation Oncology, 75005 Paris, France.
  • Dendale R; Institut Curie, Department of Radiation Oncology, 75005 Paris, France.
  • Kirova Y; Institut Curie, Department of Radiation Oncology, 75005 Paris, France. Electronic address: youlia.kirova@curie.fr.
Cancer Radiother ; 25(8): 779-785, 2021 Dec.
Article in En | MEDLINE | ID: mdl-34275748

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Hodgkin Disease / Proton Therapy / Mediastinal Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Cancer Radiother Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Hodgkin Disease / Proton Therapy / Mediastinal Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Cancer Radiother Year: 2021 Document type: Article